Clesrovimab Pregnancy and Breastfeeding Warnings
Brand names: Enflonsia
Medically reviewed by Drugs.com. Last updated on Jul 15, 2025.
Clesrovimab Pregnancy Warnings
This drug is not indicated for use in females of reproductive potential.
Risk summary: No data are available on the use of this drug in pregnant women to inform a drug-related risk.
Animal studies have not been reported. There are no controlled data in human pregnancy.
Clesrovimab Breastfeeding Warnings
This drug is not indicated for use in females of reproductive potential.
Excreted into human milk: Data not available
Excreted into animal milk: Data not available
Comments:
-There is no information regarding this drug on the presence in human milk, the effects on a breastfed infant, or effects on milk production.
See also
References for pregnancy information
- (2025) "Product Information. Enflonsia Prefilled Syringe (cvx 332) (clesrovimab (cvx 332))." Merck Sharp & Dohme LLC
References for breastfeeding information
- (2025) "Product Information. Enflonsia Prefilled Syringe (cvx 332) (clesrovimab (cvx 332))." Merck Sharp & Dohme LLC
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.